5-119452586-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000414.4(HSD17B4):āc.11C>Gā(p.Pro4Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000279 in 1,614,044 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000414.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSD17B4 | NM_000414.4 | c.11C>G | p.Pro4Arg | missense_variant | 1/24 | ENST00000510025.7 | NP_000405.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSD17B4 | ENST00000510025.7 | c.11C>G | p.Pro4Arg | missense_variant | 1/24 | 2 | NM_000414.4 | ENSP00000424940 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000191 AC: 48AN: 250928Hom.: 0 AF XY: 0.000243 AC XY: 33AN XY: 135632
GnomAD4 exome AF: 0.000290 AC: 424AN: 1461750Hom.: 1 Cov.: 34 AF XY: 0.000327 AC XY: 238AN XY: 727192
GnomAD4 genome AF: 0.000177 AC: 27AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.000201 AC XY: 15AN XY: 74462
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 03, 2024 | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 35326346, 30692775) - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 02, 2017 | Variant classified as Uncertain Significance - Favor Benign. The p.Pro4Arg varia nt in HSD17B4 has not been previously reported in individuals with hearing loss, bi-functional protein deficiency (BPD), or Perrault syndrome. It has been ident ified in 36/126190 European by the Genome Aggregation Database (gnomAD, http://g nomad.broadinstitute.org; dbSNP rs142889209). Although this variant has been see n in the general population, its frequency is not high enough to rule out a path ogenic role. Computational prediction tools suggest that the p.Pro4Arg variant m ay not impact the protein, though this information is not predictive enough to r ule out pathogenicity. In summary, the clinical significance of the p.Pro4Arg va riant is uncertain. - |
Bifunctional peroxisomal enzyme deficiency Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 17, 2020 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2021 | The c.11C>G (p.P4R) alteration is located in exon 1 (coding exon 1) of the HSD17B4 gene. This alteration results from a C to G substitution at nucleotide position 11, causing the proline (P) at amino acid position 4 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Bifunctional peroxisomal enzyme deficiency;C0685838:Perrault syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at